Nervous System Diseases

• 

  Subject Areas on Research

  • "Other" neurologic complications after cardiac surgery. 
  • 2025: the practice of neurology: back from the future. 
  • A double-injection model of intracerebral hemorrhage in rabbits. 
  • A model for slow axonal transport and its application to neurofilamentous neuropathies. 
  • A potential role for interferon-alpha in the pathogenesis of HIV-associated dementia. 
  • A role for GAPDH in apoptosis and neurodegeneration. 
  • Acquired immunodeficiency syndrome (AIDS). 
  • Acrylamide increases in vitro calcium and calmodulin-dependent kinase-mediated phosphorylation of rat brain and spinal cord neurofilament proteins. 
  • Acupuncture application for neurological disorders. 
  • Adenosine-induced flow arrest to facilitate intracranial aneurysm clip ligation does not worsen neurologic outcome. 
  • Adenosine-induced flow arrest to facilitate intracranial aneurysm clip ligation: dose-response data and safety profile. 
  • Advances in pediatric neuroradiology: highlights of the recent medical literature. 
  • Adverse effects of FK 506 overdosage after liver transplantation. 
  • Amplification of HIV-1 provirus from cerebrospinal fluid and its correlation with neurologic disease. 
  • An Analysis of the Incidence and Outcomes of Major Versus Minor Neurological Decline After Complex Adult Spinal Deformity Surgery: A Subanalysis of Scoli-RISK-1 Study. 
  • Analyzing change in recovery patterns in the year after acute hospitalization. 
  • Anticholinergic drugs and elderly people: a no brainer? 
  • Apolipoprotein E and neurological disease: therapeutic potential and pharmacogenomic interactions. 
  • Apolipoprotein E genotype and S100beta after cardiac surgery: is inflammation the link? 
  • Apolipoprotein E genotype and outcome in infants with hypoxic-ischemic encephalopathy. 
  • Apolipoprotein E-derived peptides reduce CNS inflammation: implications for therapy of neurological disease. 
  • Apoptosis in development and disease of the nervous system: II. Apoptosis in childhood neurologic disease. 
  • Assessment of the delayed neurotoxicity of tributyl phosphate, tributoxyethyl phosphate, and dibutylphenyl phosphate. 
  • Association between cyclosporin neurotoxicity and hypomagnesaemia. 
  • Association of traumatic brain injury with subsequent neurological and psychiatric disease: a meta-analysis. 
  • Astrocytes Assemble Thalamocortical Synapses by Bridging NRX1α and NL1 via Hevin. 
  • Autoimmunity and neurological disease: antibody modulation of synaptic transmission. 
  • Automatic analysis of the electromyographic interference pattern using the turns: amplitude ratio. 
  • Bartonella sp. bacteremia in patients with neurological and neurocognitive dysfunction. 
  • Be good, communicate, and collaborate: a qualitative analysis of stakeholder perspectives on adding a chiropractor to the multidisciplinary rehabilitation team. 
  • Brain stimulation in neurology and psychiatry: perspectives on an evolving field. 
  • CYP7B1: one cytochrome P450, two human genetic diseases, and multiple physiological functions. 
  • Calculation of the percentage of a narcotic gas to permit abolition of the high pressure nervous syndrome. 
  • Carbon monoxide poisoning. 
  • Cardiac Dysfunction After Neurologic Injury: What Do We Know and Where Are We Going? 
  • Cardiopulmonary bypass and long-term neurocognitive dysfunction in the rat. 
  • Cardiopulmonary bypass induces neurologic and neurocognitive dysfunction in the rat. 
  • Cardiovascular manifestations of neurologic disease. 
  • Cellular niches for endogenous neural stem cells in the adult brain. 
  • Characterization of delayed neurotoxicity in the mouse following chronic oral administration of tri-o-cresyl phosphate. 
  • Chlorpyrifos exposure during a critical neonatal period elicits gender-selective deficits in the development of coordination skills and locomotor activity. 
  • Chromosomal localization of the ankyrinG gene (ANK3/Ank3) to human 10q21 and mouse 10. 
  • Chronic Musculoskeletal Pain is a Nervous System Disorder… Now What? 
  • Clinical trials in progressive neurological diseases. Recruitment, enrollment, retention and compliance. 
  • Cluneal neuropathy. 
  • Coexisting endogenous and exogenous lipoid pneumonia and pulmonary alveolar proteinosis in a patient with neurodevelopmental disease. 
  • Collagenolytic activity of the skin associated with neuromuscular diseases including amyotrophic lateral sclerosis. 
  • Common mononeuropathies. 
  • Community-, facility-, and individual-level outcomes of a district mental healthcare plan in a low-resource setting in Nepal: A population-based evaluation. 
  • Comorbidity of depression with other medical diseases in the elderly. 
  • Comparison of MRI and MRA findings in children with a variety of neurologic conditions. 
  • Complications associated with traction on the hip during arthroscopy. 
  • Continuing education course #1: non-invasive imaging as a problem-solving tool and translational biomarker strategy in toxicologic pathology. 
  • Continuing education course #3: current practices and future trends in neuropathology assessment for developmental neurotoxicity testing. 
  • Controlling robots with the mind. 
  • Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results. 
  • Correlation of leukocytosis with early neurological deterioration following supratentorial intracerebral hemorrhage. 
  • Coumaphos: delayed neurotoxic effect following dermal administration in hens. 
  • Current best practices and guidelines. Assessment and management of complications in infective endocarditis. 
  • Cytokines and neurodevelopmental outcomes in extremely low birth weight infants. 
  • Decreased suppressor-inducer T lymphocytes in multiple sclerosis and other neurological diseases. 
  • Delayed neuropsychologic dysfunction after liver transplantation for acute liver failure: a matched, case-controlled study. 
  • Delayed neurotoxic, late acute and cholinergic effects of S,S,S-tributyl phosphorotrithioate (DEF): subchronic (90 days) administration in hens. 
  • Delayed neurotoxicity induced by organophosphorus compounds in the wild mallard duckling: effect of leptophos. 
  • Delayed neurotoxicity of O-ethyl O-2,4-dichlorophenyl phenylphosphonothioate: effects of a single oral dose on hens. 
  • Delayed neurotoxicity of O-ethyl O-4-nitrophenyl phenylphosphonothioate: subchronic (90 days) oral administration in hens. 
  • Delayed neurotoxicity of O-ethyl O-4-nitrophenyl phenylphosphonothioate: toxic effects of a single oral dose on the nervous system of hens. 
  • Delayed neurotoxicity of leptophos and related compounds: differential effects of subchronic oral administration of pure, technical grade and degradation products on the hen. 
  • Delayed neurotoxicity of subchronic oral administration of leptophos to hens: recovery during four months after exposure. 
  • Dentatorubral-pallidoluysian atrophy and Haw River syndrome. 
  • Depression in elderly hospitalized patients with medical illness. 
  • Detection of activated terminal complement (C5b-9) in cerebrospinal fluid from patients with central nervous system involvement of primary Sjogren's syndrome or systemic lupus erythematosus. 
  • Development of a neuro early mobilisation protocol for use in a neuroscience intensive care unit. 
  • Diagnostic exome sequencing: a new paradigm in neurology. 
  • Differences in quality between privately and publicly banked umbilical cord blood units: a pilot study of autologous cord blood infusion in children with acquired neurologic disorders. 
  • Differential metabolism of O-ethyl O-4-nitrophenyl phenylphosphonothioate by rat and chicken hepatic microsomes. 
  • Diisopropyl phosphorofluoridate (DFP) treatment alters calcium-activated proteinase activity and cytoskeletal proteins of the hen sciatic nerve. 
  • Disparities in Neurotoxicity Risk and Outcomes among Pediatric Acute Lymphoblastic Leukemia Patients. 
  • Distinct neurological disorders with ATP1A3 mutations. 
  • Domestic violence in neurologic practice. 
  • Duration of Adjuvant Chemotherapy for Stage III Colon Cancer. 
  • Early biochemical detection of delayed neurotoxicity resulting from developmental exposure to chloropyrifos. 
  • Effect of age on outcomes after left ventricular assist device placement. 
  • Effect of nitrous oxide use on long-term neurologic and neuropsychological outcome in patients who received temporary proximal artery occlusion during cerebral aneurysm clipping surgery. 
  • Effect of subchronic dermal application of O-ethyl O-4-nitrophenyl phenylphosphonothioate on producing delayed neurotoxicity in hens. 
  • Effects of a dermal dose of S,S,S,-tri-n-butyl phosphorotrithioate on brain acetylcholinesterase, acid phosphatase, and 2',3'-cyclic nucleotide-3' phosphohydrolase and plasma butyrylcholinesterase in hens. 
  • Electrophysiologic, ischemic, inflammatory, genetic, and neurogenic factors in the etiology of atrial fibrillation. 
  • Embryonic lethal abnormal visual RNA-binding proteins involved in growth, differentiation, and posttranscriptional gene expression. 
  • Emerging targets in neuroinflammation-driven chronic pain. 
  • Epstein-Barr in acute nontraumatic mononeuropathies. 
  • Errors in surgical neuropathology and the influence of cognitive biases: the psychology of intelligence analysis. 
  • Ethylmalonic aciduria: an organic acidemia with CNS involvement and vasculopathy. 
  • Evaluation of Nissen fundoplication in neurologically impaired children. 
  • Evaluation of an automatic method of measuring features of motor unit action potentials. 
  • Evidence-based decision support for neurological diagnosis reduces errors and unnecessary workup. 
  • Evidence-based systematic review: Oropharyngeal dysphagia behavioral treatments. Part III--impact of dysphagia treatments on populations with neurological disorders. 
  • Expression of amphiphysin I, an autoantigen of paraneoplastic neurological syndromes, in breast cancer. 
  • FAK/Src family of kinases: protective or aggravating factor for ischemia reperfusion injury in nervous system? 
  • Finding neuroelectric activity under magnetic-field oscillations (NAMO) with magnetic resonance imaging in vivo. 
  • Frequency and Acceptability of Adverse Events After Anterior Cervical Discectomy and Fusion: A Survey Study From the Cervical Spine Research Society. 
  • From genes to mechanisms to therapies: lessons to be learned from neurological disorders. 
  • Functional polymorphisms of the brain serotonin synthesizing enzyme tryptophan hydroxylase-2. 
  • Fungal infection of a ventriculoperitoneal shunt: histoplasmosis diagnosis and treatment. 
  • Generalized Periodic Discharges: A Topical Review. 
  • Genetic engineering of mesenchymal stem cells and its application in human disease therapy. 
  • Genetic models in pharmacology: present status and future. 
  • Genomics of human health and aging. 
  • Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. 
  • Hand weakness in the elderly. 
  • Head injuries. Initial evaluation and management. 
  • Hereditary spastic paraplegia: advances in genetic research. Hereditary Spastic Paraplegia Working group. 
  • High-risk populations identified in Childhood Cancer Survivor Study investigations: implications for risk-based surveillance. 
  • Histopathological assessment of triphenyl phosphite neurotoxicity in the hen. 
  • Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. 
  • Hybrid procedures in the treatment of thoracoabdominal aortic aneurysms: a systematic review. 
  • Hyperbaric oxygen therapy for treatment of neurologic sequela after atrioesophageal fistula. 
  • Hypoglossal neuropathy in hereditary neuropathy with liability to pressure palsy. 
  • Hysterical conversion reactions mimicking neurological disease. 
  • IFN-gamma production in response to neuropathogenic Cas-Br-M murine leukemia virus infection. 
  • Identification of a common epitope between enterovirus 71 and human MED25 proteins which may explain virus-associated neurological disease. 
  • Iliac artery pseudoaneurysm following renal transplantation presenting as lumbosacral plexopathy. 
  • Immune-related Neurological Symptoms in an Adolescent Patient Receiving the Checkpoint Inhibitor Nivolumab. 
  • In-Flight Injuries Involving Children on Commercial Airline Flights. 
  • Inborn errors of molybdenum metabolism: combined deficiencies of sulfite oxidase and xanthine dehydrogenase in a patient lacking the molybdenum cofactor. 
  • Incidence and risk factors of postoperative neurologic decline after complex adult spinal deformity surgery: results of the Scoli-RISK-1 study. 
  • Incorporating Functional Information in Tests of Excess De Novo Mutational Load. 
  • Increased neurotoxicity following concurrent exposure to pyridostigmine bromide, DEET, and chlorpyrifos. 
  • Index of suspicion. Case 1: Infant who has respiratory distress. Case 2: Abnormal behavior, seizures, and altered sensorium in a 7-year-old boy. Case 3: Fever and dysphagia in a 4-year-old girl. 
  • Influence of Single-Dose Antibiotic Prophylaxis for Early-Onset Pneumonia in High-Risk Intubated Patients. 
  • Influence of acidosis, hypoxemia, and hypotension on neurodevelopmental outcome in very low birth weight infants. 
  • Influenza vaccination practices of physicians and caregivers of children with neurologic and neurodevelopmental conditions - United States, 2011-12 influenza season. 
  • Integrative functional genomic analysis of human brain development and neuropsychiatric risks. 
  • Interaction between neurotoxicities induced by organophosphorus and long-chain hexacarbon compounds. 
  • Interneurons from embryonic development to cell-based therapy. 
  • Intraamniotic Zika virus inoculation of pregnant rhesus macaques produces fetal neurologic disease. 
  • Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results. 
  • Isolated deficiency of vitamin E with progressive neurologic deterioration. 
  • Isolated sulfite oxidase deficiency: review of two cases in one family. 
  • Lack of Duffy antigen expression is associated with organ damage in patients with sickle cell disease. 
  • Lack of delayed neurotoxic effect after tri-o-cresyl phosphate treatment in male Fischer 344 rats: biochemical, neurobehavioral, and neuropathological studies. 
  • Large-scale mutagenesis of the mouse to understand the genetic bases of nervous system structure and function. 
  • Late onset of distinct neurologic syndromes in galactosemic siblings. 
  • Lhermitte's sign in cobalamin (vitamin B12) deficiency. 
  • Long-term efficacy of microvascular decompression in trigeminal neuralgia. 
  • Long-term neurologic health and psychosocial function of adult survivors of childhood medulloblastoma/PNET: a report from the Childhood Cancer Survivor Study. 
  • Macrophage markers in diagnostic neuropathology. 
  • Management of Sickle Cell Disease in Children. 
  • Mechanisms of organophosphorus ester-induced delayed neurotoxicity: type I and type II. 
  • Medical comorbidity in women and men with schizophrenia: a population-based controlled study. 
  • MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction. 
  • Microtubule transport defects in neurological and ciliary disease. 
  • Mode of action: disruption of brain cell replication, second messenger, and neurotransmitter systems during development leading to cognitive dysfunction--developmental neurotoxicity of nicotine. 
  • Modified open-door laminoplasty for treatment of neurological deficits in younger patients with congenital spinal stenosis: analysis of clinical and radiographic data. 
  • Molybdenum cofactor deficiency associated with Dandy-Walker malformation. 
  • Mononeuropathies in pregnancy. 
  • Monosynaptic reflex depression in cats with organophosphorus neuropathy: effects of tri-o-cresyl phosphate. 
  • Morbidity and mortality in the surgical treatment of six hundred five pediatric patients with isthmic or dysplastic spondylolisthesis. 
  • More evidence for the benefits of cognitive activity over the lifespan. 
  • Mycobacterium tuberculosis polymerase chain reaction findings in neurosarcoidosis. 
  • Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets. 
  • NIH Neural Interfaces Workshop: August 21-23, 2006, Bethesda, MD, USA. 
  • NIH Roundtable on Opportunities to Advance Research on Neurologic and Psychiatric Emergencies. 
  • Necrotizing neurosarcoidosis of the cranial base resembling an en plaque sphenoid wing meningioma: case report. 
  • Neural autoantibodies in patients with neurological symptoms and histories of chemical/mold exposures. 
  • Neuregulins as potential drugs for neurological disorders. 
  • Neuro-ophthalmology Safer Than MRI? 
  • Neuroinflammation and Perioperative Neurocognitive Disorders. 
  • Neurologic Deficits Have a Negative Impact on Patient-Related Outcomes in Primary Presentation Adult Symptomatic Lumbar Scoliosis Surgical Treatment at One-Year Follow-up. 
  • Neurologic Outcome After Prematurity: Perspectives of Parents and Clinicians. 
  • Neurologic and Functional Morbidity in Critically Ill Children With Bronchiolitis. 
  • Neurologic aspects of drug abuse. 
  • Neurologic intensive care unit monitoring. 
  • Neurologic manifestations of hematologic disease. 
  • Neurologic sequelae in the survivors of neonatal intraventricular hemorrhage. 
  • Neurologic symptoms associated with raising poultry and swine among participants in the Agricultural Health Study. 
  • Neurological and psychiatric tolerability of rilpivirine (TMC278) vs. efavirenz in treatment-naïve, HIV-1-infected patients at 48 weeks. 
  • Neurological complications of cardiac surgery. 
  • Neurological complications of systemic cancer. 
  • Neurological disorders with abnormalities of immunoglobulin metabolism. 
  • Neurological manifestations of malignancies. 
  • Neurological signs in congenital iodine-deficiency disorder (endemic cretinism). 
  • Neurology and diving. 
  • Neuron specific alpha-adrenergic receptor expression in human cerebellum: implications for emerging cerebellar roles in neurologic disease. 
  • Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain. 
  • Neuropalliative care: Priorities to move the field forward. 
  • Neuropathies of pregnancy. 
  • Neuropeptides and neurotransmitters in Alzheimer's disease: focus on corticotrophin releasing factor. 
  • Neuroprotection in cardiac surgery. 
  • Neuropsychiatric manifestations of porphyria. 
  • Neuropsychological performance at the age of 13 years and adult schizophreniform disorder: prospective birth cohort study. 
  • Neurotoxicity of continuous (90 days) inhalation of technical grade methyl butyl ketone in hens. 
  • New paradigms in cardiovascular medicine: emerging technologies and practices: perioperative genomics. 
  • No association between intraoperative hypothermia or supplemental protective drug and neurologic outcomes in patients undergoing temporary clipping during cerebral aneurysm surgery: findings from the Intraoperative Hypothermia for Aneurysm Surgery Trial. 
  • Nomogram for Predicting Time to Death After Withdrawal of Life-Sustaining Treatment in Patients With Devastating Neurological Injury. 
  • Nrf2, a multi-organ protector? 
  • One-year outcome in 232 premature infants with birth weights of 750 to 1249 grams and respiratory distress syndrome randomized to rescue treatment with two doses of synthetic surfactant or air placebo. Canadian Exosurf Neonatal Study Group. 
  • Open heart surgery and cognitive decline. 
  • Organophosphorus ester-induced delayed neurotoxicity. 
  • Osteoporosis piece of multi-morbidity puzzle in geriatric care. 
  • Outcome at 1-year adjusted age of 957 infants weighing more than 1250 grams with respiratory distress syndrome randomized to receive synthetic surfactant or air placebo. American and Canadian Exosurf Neonatal Study Groups. 
  • Palliative care in neonatal neurology: robust support for infants, families and clinicians. 
  • Patient selection in congenital pyriform aperture stenosis repair - 14 year experience and systematic review of literature. 
  • Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications. 
  • Pharmacogenomic effects of apolipoprotein e on intracerebral hemorrhage. 
  • Phase I evaluation of 773U82.HCl, a member of a new class of DNA intercalators. 
  • Phase I evaluation of crisnatol (BWA770U mesylate) on a monthly extended infusion schedule. 
  • Phase I trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU) terminated by severe neurologic toxicity. 
  • Physician Beliefs about Physical and Mental Competency of Patients Applying for Concealed Weapon Permits. 
  • Plasma Glycoproteomic Study of Therapeutic Hypothermia Reveals Novel Markers Predicting Neurologic Outcome Post-cardiac Arrest. 
  • Postural hypotension. 
  • Predictors of Complications of Tonsillectomy With or Without Adenoidectomy in Hospitalized Children and Adolescents in the United States, 2001-2010: A Population-Based Study. 
  • Preimplantation genetic diagnosis for inherited neurological disorders. 
  • Propofol sedation for longitudinal pediatric neuroimaging research. 
  • Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative. 
  • Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative. 
  • Psychotic symptoms in patients with medical disorders. 
  • Quiet time: a nursing intervention to promote sleep in neurocritical care units. 
  • Quinolinic acid in neurological disease: opportunities for novel drug discovery. 
  • Rates of new neurological deficit associated with spine surgery based on 108,419 procedures: a report of the scoliosis research society morbidity and mortality committee. 
  • Re: Transient lower extremity neurapraxia associated with radical perineal prostatectomy: a complication of the exaggerated lithotomy position. 
  • Reactive oxygen species: from health to disease. 
  • Recombinant DNA strategies in genetic neurological diseases. 
  • Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial. 
  • Rem sleep behavior disorder: potential relationship to post-traumatic stress disorder. 
  • Respiratory management in acute neurologic illness. 
  • Retinitis pigmentosa, pigmentary retinopathies, and neurologic diseases. 
  • Retrospective analysis underestimates neurological deficits in complex spinal deformity surgery: a Scoli-RISK-1 Study. 
  • Role of acid phosphatase in delayed neurotoxicity induced by leptophos in hens. 
  • Safeguards to prevent neurologic complications after epidural steroid injections: consensus opinions from a multidisciplinary working group and national organizations. 
  • Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. 
  • Sarin: health effects, metabolism, and methods of analysis. 
  • Short- and long-term prognosis among veterans with neurological disorders and subsequent lower-extremity amputation. 
  • Short-term complications associated with surgery for high-grade spondylolisthesis in adults and pediatric patients: a report from the scoliosis research society morbidity and mortality database. 
  • Single fiber electromyography. 
  • Soft neurologic signs. 
  • Some uncommon acute neurological disorders. 
  • Stathmin-deficient mice develop an age-dependent axonopathy of the central and peripheral nervous systems. 
  • Stem cell therapy for neurologic disorders: therapeutic potential of adipose-derived stem cells. 
  • Studies of the molecular pathogenesis of hexane neuropathy. II. Evidence that pyrrole derivatization of lysyl residues leads to protein crosslinking. 
  • Survey of anesthesiologists practicing in American neurointensive care units as neurointensivists. 
  • Survey of health status and complications among propionic acidemia patients. 
  • Targeting RNA in mammalian systems with small molecules. 
  • Tarlov cysts: a controversial lesion of the sacral spine. 
  • Tear gas: an epidemiological and mechanistic reassessment. 
  • Temporal Changes in Prescription of Neuropharmacologic Drugs and Utilization of Resources Related to Neurologic Morbidity in Mechanically Ventilated Children With Bronchiolitis. 
  • Tethered cord due to spina bifida occulta presenting in adulthood: a tricenter review of 61 patients. 
  • The Intolerance of Regulatory Sequence to Genetic Variation Predicts Gene Dosage Sensitivity. 
  • The Neurostimulation Appropriateness Consensus Committee (NACC) Safety Guidelines for the Reduction of Severe Neurological Injury. 
  • The cytoskeleton as a target for organophosphorus ester-induced delayed neurotoxicity (OPIDN). 
  • The efficacy of endosaccular aneurysm occlusion in alleviating neurological deficits produced by mass effect. 
  • The endoplasmic reticulum and neurological diseases. 
  • The evolving role of gene-based treatment in surgery. 
  • The future of implantable neuroprosthetic devices: ethical considerations. 
  • The genetics of neuropsychiatric diseases: looking in and beyond the exome. 
  • The health impacts of heat waves in five regions of New South Wales, Australia: a case-only analysis. 
  • The joint neurotoxic action of inhaled methyl butyl ketone vapor and dermally applied O-ethyl O-4-nitrophenyl phenylphosphonothioate in hens: potentiating effect. 
  • The molecular genetic revolution. Its impact on clinical neurology. 
  • The new approach to assignment of ASFA categories--introduction to the fourth special issue: clinical applications of therapeutic apheresis. 
  • The status and future of acupuncture clinical research. 
  • The synergism of n-hexane-induced neurotoxicity by methyl isobutyl ketone following subchronic (90 days) inhalation in hens: induction of hepatic microsomal cytochrome P-450. 
  • The uptake of methyl mercury (203Hg) in different tissues related to its neurotoxic effects. 
  • The value of magnetic resonance imaging in the evaluation of fatty filum terminale. 
  • Therapy with bortezomib plus lenalidomide for relapsed/refractory mantle cell lymphoma: final results of a phase II trial (CALGB 50501). 
  • Thoracoscopic sympathectomy in the management of vasomotor disturbances and complex regional pain syndrome of the hand. 
  • Toward a convergence of regenerative medicine, rehabilitation, and neuroprosthetics. 
  • Transcatheter occlusion of patent foramen ovale: a prevention for decompression illness? 
  • Transient lower extremity neurapraxia associated with radical perineal prostatectomy: a complication of the exaggerated lithotomy position. 
  • Tumor necrosis factor α antagonism improves neurological recovery in murine intracerebral hemorrhage. 
  • Two novel alleles of tottering with distinct Ca(v)2.1 calcium channel neuropathologies. 
  • Ultraviolet-light-inactivated Cas-Br-M murine leukemia virus induces a protective CD8+ cytotoxic T lymphocyte response in newborn mice. 
  • Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary. 
  • Use of extracorporeal life support in patients with congenital heart disease. 
  • Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. 
  • Using human neural stem cells to model neurological disease. 
  • Utility of postmortem magnetic resonance imaging in clinical neuropathology. 
  • Uveitis with neurological manifestations. 
  • Video training and certification program improves reliability of postischemic neurologic deficit measurement in the rat. 
  • Virtual neuropathology: three-dimensional visualization of lesions due to toxic insult. 
  • Warning SINEs: Alu elements, evolution of the human brain, and the spectrum of neurological disease. 
  • Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. 
  • Work-site clinical and neurobehavioral assessment of solvent-exposed microelectronics workers. 
  • [Neurology and cardiology: points of contact]. 
• 

  Keywords of People

  • Bennett, Vann, George B. Geller Distinguished Professor for Research in Molecular Biology in the School of Medicine, Duke Cancer Institute
  • Berger, Miles, Assistant Professor of Anesthesiology, Duke Science & Society
  • Bradford, William Dalton, Professor of Pathology, Pathology
  • James, Michael Lucas, Associate Professor of Anesthesiology, Anesthesiology, Neuroanesthesia
  • Laskowitz, Daniel Todd, Professor of Neurology, Duke Innovation & Entrepreneurship
  • McConnell, Eleanor Schildwachter, Associate Professor in the School of Nursing, with tenure, School of Nursing
  • McLendon, Roger Edwin, Professor of Pathology, Pathology
  • Milano, Carmelo Alessio, Professor of Surgery, Surgery, Cardiovascular and Thoracic Surgery
  • Nicolelis, Miguel Angelo L., Duke School of Medicine Professor in Neuroscience, Psychology and Neuroscience
  • Swaminathan, Madhav, Professor of Anesthesiology, Anesthesiology, Cardiothoracic
  • Warner, David Samuel, Distinguished Distinguished Professor of Anesthesiology, in the School of Medicine, Neurobiology